Fact sheet: Invesco Global Health Care

Fund information

Fund name
Invesco Global Health Care A USD
Fund company manager
Invesco Global Asset Mgmt Ltd
Fund type
SIB
Fund manager(s)
Henry Wu
since 30/04/2017
Derek Taner
since 01/01/2006
Fund objective
The Fund aims to achieve long term capital growth by investing in shares of healthcare companies throughout the world. For the full objectives and investment policy please consult the current prospectus.
Benchmark
MSCI World Health Care
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

14.5 %

1 Year rank in sector

14/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 467.6 m

FE Risk score

170

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    82.5%
  • Switzerland
    5.1%
  • Germany
    2.7%
  • France
    2.6%
  • Japan
    2.1%
  • Biotechnology/Medical
    46.9%
  • Pharmaceuticals
    27%
  • Health Care
    15%
  • Healthcare & Medical Products
    8.6%
  • Conglomerates
    1.2%
  • US Equities
    82.5%
  • Swiss Equities
    5.1%
  • German Equities
    2.7%
  • French Equities
    2.6%
  • Japanese Equities
    2.1%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund0.46 %10.6 %14.5 %12.12 %63.6 %
Sector1.18 %8.1 %14.79 %27.68 %100.39 %
Rank within sector26 / 3113 / 3114 / 3025 / 2823 / 24
Quartile th4 th2 nd2 nd4 th4 th

Calendar performance

YTD-20172016201520142013
Fund17.6 %-13.51 %1.02 %19.31 %37.53 %
Sector17.13 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector14 / 3018 / 3026 / 2823 / 2513 / 24
Quartile th2 nd3 rd4 th4 th3 rd

Risk statistics

Alpha-4.7
Beta1.02
Sharpe-0
Volatility16.47
Tracking error5.18
Information ratio-0.91
R-Squared0.9

Price movement

52 week high134.03
52 week low106.49
Current bid price0
Current offer price0
Current mid price132.45

Holdings by region

  • 82.5% USA
  • 5.1% Switzerland
  • 2.7% Germany
  • 2.6% France
  • 2.1% Japan
  • 1.2% Netherlands
  • 1.2% UK
  • 1% Brazil
  • 0.8% Money Market
  • 0.8% Others

Holdings by sector

  • 46.9% Biotechnology/Medical
  • 27% Pharmaceuticals
  • 15% Health Care
  • 8.6% Healthcare & Medical Products
  • 1.2% Conglomerates
  • 0.8% Money Market
  • 0.5% Food & Drug Retailers

Holdings by asset type

  • 82.5% US Equities
  • 5.1% Swiss Equities
  • 2.7% German Equities
  • 2.6% French Equities
  • 2.1% Japanese Equities
  • 1.2% Dutch Equities
  • 1.2% UK Equities
  • 1% Brazilian Equities
  • 0.8% International Equities
  • 0.8% Money Market

Individual holdings

  • 6% CELGENE CORP
  • 4.2% ALEXION PHARMACEUTICALS INC
  • 4% THERMO FISHER SCIENTIFIC INC
  • 3.9% SHIRE PLC
  • 3.6% BIOMARIN PHARMACEUTICAL
  • 3.4% BRISTOL MYERS SQUIBB SA
  • 3.1% LILLY (ELI) & CO
  • 3% AETNA INC
  • 2.9% BIOGEN INC
  • 2.9% UNITEDHEALTH GROUP INC